Solid Biosciences Inc. (SLDB): Price and Financial Metrics
SLDB Price/Volume Stats
| Current price | $4.96 | 52-week high | $15.05 |
| Prev. close | $5.11 | 52-week low | $2.32 |
| Day low | $4.90 | Volume | 376,800 |
| Day high | $5.10 | Avg. volume | 345,014 |
| 50-day MA | $6.37 | Dividend yield | N/A |
| 200-day MA | $8.46 | Market Cap | 198.18M |
SLDB Stock Price Chart Interactive Chart >
Solid Biosciences Inc. (SLDB) Company Bio
Solid Biosciences, LLC engages in identifying and developing gene therapies for duchenne muscular dystrophy in the United States. Its lead product candidate includes SGT-001, a gene transfer candidate that is in Phase I/II clinical trial to restore functional dystrophin protein expression in patients’ muscles. The company was formerly known as Solid Ventures, LLC and changed its name to Solid Biosciences, LLC in June 2015. Solid Biosciences, LLC was founded in 2013 and is based in Cambridge, Massachusetts.
SLDB Price Returns
| 1-mo | -12.98% |
| 3-mo | -48.12% |
| 6-mo | -36.33% |
| 1-year | 89.31% |
| 3-year | -82.41% |
| 5-year | -92.31% |
| YTD | -19.22% |
| 2023 | 14.13% |
| 2022 | -79.50% |
| 2021 | -76.91% |
| 2020 | 70.34% |
| 2019 | -83.40% |
Loading social stream, please wait...